|1.||Walochnik, Julia: 3 articles (03/2014 - 01/2003)|
|2.||Di Renzo, G C: 3 articles (12/2012 - 09/2003)|
|3.||Gerli, S: 3 articles (12/2012 - 09/2003)|
|4.||Perfect, John R: 3 articles (09/2011 - 08/2003)|
|5.||Kramer, A: 3 articles (01/2010 - 04/2004)|
|6.||Aramwit, Pornanong: 2 articles (10/2015 - 01/2011)|
|7.||Kong, Hyun-Hee: 2 articles (07/2015 - 12/2006)|
|8.||Chung, Dong-Il: 2 articles (07/2015 - 12/2006)|
|9.||Woo, Kevin Y: 2 articles (11/2014 - 02/2011)|
|10.||Leaper, David J: 2 articles (01/2013 - 12/2012)|
01/01/2013 - "One small blinded study of 38 patients found that the risk of pin site infection was significantly reduced with polyhexamethylene biguanide (PHMB) gauze when compared to plain gauze (RR 0.23, 95% CI 0.12 to 0.44) (infection rate of 1% in the PHMB group and 4.5% in the control group) but this study was at high risk of bias as the unit of analysis was observations rather than patients. "
01/01/2012 - " study was carried out to evaluate the effectiveness of a long term polyhexamethylene biguanide (PHMB)-based local treatment in improving the viral clearance, reducing the time exposure to the infection and avoiding the complications associated with the invasive treatments currently available. "
08/01/2012 - "To prevent common clinical infections, an antimicrobial agent, polyhexamethylene biguanide (PHMB) was incorporated into the electrospun fibers. "
02/01/2012 - "Use of polyhexamethylene biguanide-impregnated gauze can reduce the risk of pin tract infection in external fixation. "
02/01/2012 - "The infection rate was lower (χ(2) [1, n = 1932] = 23.00) and the risk for infection was lower (relative risk, 0.228; 95% confidence interval, 0.118, 0.443) for the polyhexamethylene biguanide group (n = 1068; 1.0%) than for the control group (n = 864; 4.5%). "
|2.||Wounds and Injuries (Trauma)
11/01/2006 - "Use of Lavasept led to a faster and significant reduction in microorganisms on the wound surfaces. "
03/08/2012 - "A foam dressing impregnated with polyhexamethylene biguanide was used at the wound interface, providing a safe and effective alternative to managing overgranulation. "
08/01/2004 - "Polymicrobial counts in the treatment group remained reduced for the following three study weeks, returning to baseline at Week 4. In the control group, the number of polymicrobial cultures rose to 60% above baseline at Week 4. Two wounds of subjects randomized to the polyhexamethylene biguanide antimicrobial gauze healed; one wound in the control group healed. "
12/02/2015 - "Polyhexamethylene biguanide (PHMB) is a novel wound antiseptic solution that has a broad antimicrobial spectrum and wound healing promoting effect, with minimal side effects. "
08/01/2013 - "Polihexanide (polyhexamethylene biguanide) is an antiseptic substance that plays a prominent role in the treatment of critically colonized or infected acute and chronic wounds in humans. "
04/15/1993 - "We believe the addition of polyhexamethylene biguanide to our treatment regimen in Acanthamoeba keratitis dramatically aided and hastened the clinical improvement in five consecutive patients and may, with early diagnosis, increase the number of medical cures."
05/01/1998 - "Is polyhexamethylene biguanide alone effective for Acanthamoeba keratitis?"
08/01/1998 - "Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide."
02/01/1998 - "Polyhexamethylene biguanide treatment for Acanthamoeba keratitis."
01/01/1998 - "The reason for the apparent decline in incidence of Acanthamoeba keratitis is believed to be due to the introduction by industry over the last 3 years of sterile multipurpose (cleaning and disinfecting) solutions (MPS) containing polyhexamethylene biguanide to achieve their current popularity. "
09/01/2011 - "To establish polyhexamethylene biguanide (PHMB) as an effective treatment for Aspergillus keratitis in a novel murine model. "
01/01/2012 - "Benefit of polyhexamethylene biguanide in Fusarium keratitis."
08/01/2000 - "Polyhexamethylene biguanide (0.02%) alone is not adequate for treating chronic Acanthameoba keratitis."
08/01/1999 - "In-vitro activity of polyhexamethylene biguanide (PHMB) against fungal isolates associated with infective keratitis."
08/01/1997 - "Treatment of Nocardia asteroides keratitis with polyhexamethylene biguanide."
|5.||Condylomata Acuminata (Genital Wart)
11/01/2005 - "Patient-applied polyhexamethylene biguanide cream is effective for the treatment of external genital warts and has a favorable safety profile."
11/01/2005 - "The present prospective, double-blind, randomized, placebo (vehicle-controlled) trial evaluated the efficacy and safety of daily patient-applied polyhexamethylene biguanide for up to 16-weeks for the treatment of external genital warts. "
11/01/2005 - "Polyhexamethylene biguanide for treatment of external genital warts: a prospective, double-blind, randomized study."
|5.||chlorhexidine gluconate (Dyna-Hex)
|1.||Corneal Transplantation (Keratoplasty)
|4.||Negative-Pressure Wound Therapy